CDY 1.43% 7.1¢ cellmid limited

Latest news? Any clinical study to support it? In vivo and in...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 337 Posts.
    lightbulb Created with Sketch. 16
    Latest news? Any clinical study to support it? In vivo and in vitro study always yield different result. I think cancer stem cell theory is faulty and depict an incomplete picture of latest understanding on cancer. I dont put high hope on targetting multiple cancer peptide targets will be the solution, cancer cells need surrounding good cells to flourish. 

    TBH, i heard the same thing 10, 20 years ago on 7 news, nine news abc news sbs news, and this current news, the way they did it, is nothing new in cancer therapy. 
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.